Found: 6
Select item for more details and to access through your institution.
Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1223, doi. 10.3390/ijms22031223
- By:
- Publication type:
- Article
Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4887, doi. 10.3390/cancers15194887
- By:
- Publication type:
- Article
Combination of Abemaciclib following Eribulin Overcomes Palbociclib-Resistant Breast Cancer by Inhibiting the G2/M Cell Cycle Phase.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 210, doi. 10.3390/cancers14010210
- By:
- Publication type:
- Article
Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02903-x
- By:
- Publication type:
- Article
Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics.
- Published in:
- Genes, 2021, v. 12, n. 2, p. 159, doi. 10.3390/genes12020159
- By:
- Publication type:
- Article
PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 17086, doi. 10.3390/ijms242317086
- By:
- Publication type:
- Article